| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000260931.1 |
Ponatinib |
Brain lower grade glioma |
0.047817175 |
Resistant |
| ENSG00000260931.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.039057599 |
Resistant |
| ENSG00000260931.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.018060936 |
Resistant |
